Impact of specialist management on survival from radiation‐associated angiosarcoma of the breast. BJS 2018; 105: 401-409.
Published: 6th February 2018
Authors: L. Feinberg, A. Srinivasan, J. K. Singh, M. Parry, J. Stevenson, L. Jeys et al.
Radiation‐associated angiosarcoma of the breast (RAAS) is a rare complication of adjuvant radiotherapy associated with poor survival. The British Sarcoma Group guidelines recommend that all angiosarcomas are referred to a sarcoma multidisciplinary team, although there is no recommendation that patients are managed within a sarcoma service. The aims of this study were to compare survival, complete excision rates and local recurrence rates of patients managed within a sarcoma service and those managed within local hospitals.
All patients with RAAS referred to a regional sarcoma service between 1998 and 2015 were identified from prospective databases. Patient records, and radiology, pathology and operation notes were reviewed retrospectively.
Thirty‐six patients were operated on with curative intent; 26 were managed by the sarcoma service (of whom 21 underwent radical excision of the irradiated field followed by chest wall reconstruction) and ten were managed locally. Median age was 69·5 (range 43–85) years. Disease‐specific survival was significantly longer in patients managed by the sarcoma service than in those managed locally: median 91·1 (range 69·2–113·0)
Specialist management of RAAS leads to fewer local recurrences and improved disease‐specific survival. Early referral and management within specialist units is recommended.Full text
You may also be interested in
Nationwide population‐based study of trends and regional variation in breast‐conserving treatment for breast cancer.
Authors: M. C. van Maaren, L. J. A. Strobbe, L. B. Koppert, P. M. P. Poortmans, S. Siesling
Notes: Regional differences remain
Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flap.
Authors: A. Svee, M. Mani, K. Sandquist, T. Audolfsson, Y. Folkvaljon, A. E. Isern et al.
Authors: N. Patani, F. MacAskill, S. Eshelby, A. Omar, A. Kaura, K. Contractor et al.
Notes: Outcomes improve
Meta‐analysis of the diagnostic accuracy of ultrasound‐guided fine‐needle aspiration and core needle biopsy in diagnosing axillary lymph node metastasis. BJS 2018; 105: 1244-1253.
Authors: I. Balasubramanian, C. A. Fleming, M. A. Corrigan, H. P. Redmond, M. J. Kerin, A. J. Lowery et al.
Notes: Core needle biopsy better
Meta‐analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy. BJS 2018; 105: 1098-1106.
Authors: C. A. Fleming, H. M. Heneghan, D. O'Brien, D. P. McCartan, E. W. McDermott, R. S. Prichard et al.
Notes: Counselling of patients important
Breast‐conserving surgery followed by whole‐breast irradiation offers survival benefits over mastectomy without irradiation.
Authors: J. de Boniface, J. Frisell, L. Bergkvist, Y. Andersson
Notes: RT to lower axilla key?
Is axillary ultrasound imaging necessary for all patients with breast cancer?. BJS 2018; 105: 930-932.
Authors: M. Ahmed, M. Douek
Meta‐analysis of the oncological safety of autologous fat transfer after breast cancer. BJS 2018; 105: 1082-1097.
Authors: T. K. Krastev, S. J. Schop, J. Hommes, A. A. Piatkowski, E. M. Heuts, R. R. W. J. van der Hulst et al.
Notes: Lipofilling ok
Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer‐specific survival.
Authors: S. E. Ward, P. D. Richards, J. L. Morgan, G. R. Holmes, J. W. Broggio, K. Collins et al.
Notes: Surgery should be first choice
Risk of recurrence and death in patients with breast cancer after delayed deep inferior epigastric perforator flap reconstruction.
Authors: H. Adam, A. C. Docherty Skogh, Å. Edsander Nord, I. Schultz, J. Gahm, P. Hall et al.
Notes: DIEP is safe
Predictors of complications after direct‐to‐implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial. BJS 2018; 105: 1305-1312.
Authors: V. L. Negenborn, R. E. G. Dikmans, M. B. Bouman, H. A. H. Winters, J. W. R. Twisk, P. Q. Ruhé et al.
Notes: Not good for the large breast
Population‐based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node‐positive invasive lobular carcinoma of the breast. BJS 2018; 105: 987-995.
Authors: E. Morrow, A. Lannigan, J. Doughty, J. Litherland, J. Mansell, S. Stallard et al.
Notes: Less sensitive in lobular carcinoma